Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,681 to 1,700 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseases. | Clin Transl Immunology | 2020 | 33318796 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Cytokine Pathways Involved in COVID-19 After Rhinovirus Infection in Asthma Patients. | Med Sci Monit | 2020 | 33315853 | PubTator, text mining | PubMed |
| Serum Proteomics Reveals Alterations in Protease Activity, Axon Guidance, and Visual Phototransduction Pathways in Infants With In Utero Exposure to Zika Virus Without Congenital Zika Syndrome. | Front Cell Infect Microbiol | 2020 | 33312964 | PubTator, text mining | PubMed |
| Age-dependent possible role of contact-activated blood coagulation factor XII as a potential contributor to the “bradykinin storm” in COVID-19 patients | Orv Hetil | 2020 | 33310922 | PubTator, text mining | PubMed |
[Update on perioperative hypersensitivity reactions: joint document from the Brazilian Society of Anesthesiology (SBA) and Brazilian Association of Allergy and Immunology (ASBAI) - Part II: etiology and diagnosis]. | Braz J Anesthesiol | 2020 | 33308829 | PubTator, text mining | PubMed |
| Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor. | BMB Rep | 2020 | 33298249 | PubTator, text mining | PubMed |
| Hereditary angioedema caused by a premature stop codon mutation in the SERPING1 gene. | Clin Transl Allergy | 2020 | 33292549 | PubTator, text mining | PubMed |
| Review of icatibant use in the Winnipeg Regional Health Authority. | Allergy Asthma Clin Immunol | 2020 | 33292436 | PubTator, text mining | PubMed |
Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. | J Renin Angiotensin Aldosterone Syst | 2020 | 33283602 | PubTator, text mining | PubMed |
| The "sex gap" in COVID-19 trials: a scoping review. | EClinicalMedicine | 2020 | 33283178 | PubTator, text mining | PubMed |
| Differential Profile of Systemic Extracellular Vesicles From Sporadic and Familial Alzheimer's Disease Leads to Neuroglial and Endothelial Cell Degeneration. | Front Aging Neurosci | 2020 | 33281599 | PubTator, text mining | PubMed |
| Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods. | 3 Biotech | 2020 | 33251083 | PubTator, text mining | PubMed |
| Development of Neuroregenerative Gene Therapy to Reverse Glial Scar Tissue Back to Neuron-Enriched Tissue. | Front Cell Neurosci | 2020 | 33250718 | PubTator, text mining | PubMed |
| The good, the bad, and the opportunities of the complement system in neurodegenerative disease. | J Neuroinflammation | 2020 | 33239010 | PubTator, text mining | PubMed |
| Comprehensive proteomic atlas of skin biomatrix scaffolds reveals a supportive microenvironment for epidermal development. | J Tissue Eng | 2020 | 33224464 | PubTator, text mining | PubMed |
| The Constitutive Proteome of Human Aqueous Humor and Race Specific Alterations. | Proteomes | 2020 | 33217969 | PubTator, text mining | PubMed |
| Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19. | Evid Based Complement Alternat Med | 2020 | 33204291 | PubTator, text mining | PubMed |
| Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation. | Int J Mol Sci | 2020 | 33202744 | PubTator, text mining | PubMed |
| Look Alike, Sound Alike: Phenocopies in Steroid-Resistant Nephrotic Syndrome. | Int J Environ Res Public Health | 2020 | 33198123 | PubTator, text mining | PubMed |
| How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application. | Front Immunol | 2020 | 33193442 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=85